Cohesys

Supports: Profile · profileData.publicContact.publicPhone

Cohesys publishes a contact route at https://www.cohesys.ca/home#contact and its business address as 1300-661 University Avenue, Toronto, Ontario M5G 0B7.

Supports: Profile · reviewed questions.cohesys-first-conversation.context

Cohesys's public evidence establishes its current role and offering, but it does not answer every access, configuration, eligibility, maturity or buyer question needed for a first business-development conversation.

Supports: Profile · canadian footprint

Cohesys has a documented Canadian operating presence in Toronto, Ontario.

Supports: Profile · operating context

Resorbable materials; Single-piece design; Cut-to-shape configuration; Drill- and screw-free approach

Supports: Profile · operating context

Cohesys, founded in 2018 in Toronto, is developing BoneTape under investigational testing. The implant uses resorbable materials, is supplied as one piece and is designed to be cut to shape for fracture repair.

Supports: Profile · profileData.publicContact.contactPageUrl

Cohesys publishes a contact route at https://www.cohesys.ca/home#contact and its business address as 1300-661 University Avenue, Toronto, Ontario M5G 0B7.

Supports: Profile · profileData.publicContact.contactPageUrl

The official public contact pathway for Cohesys is https://www.cohesys.ca/home.

Supports: Profile · editorial profile version

Cohesys has sufficient mapped public evidence for private reviewer consideration of the shared editorial profile template.

Supports: Profile · reviewed questions.cohesys-first-conversation.question

True North Map derives this first-conversation question from the documented Cohesys capability, current evidence and the decision gap that remains.

Supports: Profile · canadian footprint

Cohesys, founded in 2018 in Toronto, is developing BoneTape under investigational testing. The implant uses resorbable materials, is supplied as one piece and is designed to be cut to shape for fracture repair. Cohesys publishes a contact route at https://www.cohesys.ca/home#contact and its business address as 1300-661 University Avenue, Toronto, Ontario M5G 0B7.

Supports: Profile · profileData.publicContact.linkedInUrl

Cohesys publishes a contact route at https://www.cohesys.ca/home#contact and its business address as 1300-661 University Avenue, Toronto, Ontario M5G 0B7.

Supports: Profile · operating context

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · technicaldomainslugs

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · defence applications

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · technology readiness level

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · defence applications

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · technical tags

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · technical tags

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · capability type

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · summary

Cohesys' BoneTape is an investigational, single-piece resorbable fixation approach designed to be cut to shape and used without the conventional drilling and screw hardware associated with plate-based fracture repair.

Supports: BoneTape resorbable fracture fixation · name

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · commercial availability

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · technicaldomainslugs

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · technical tags

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · core features

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · summary

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · technical tags

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · defence applications

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · technical tags

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation · defence applications

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation → Edge Data Processing

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation → Edge Data Processing

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation → Edge Data Processing

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: BoneTape resorbable fracture fixation → Edge Data Processing

A compact investigational fixation system may be relevant to distributed trauma-care logistics, but this is a derived relevance assessment and does not establish medical approval or military adoption.

Supports: BoneTape resorbable fracture fixation → Edge Data Processing

Cohesys describes BoneTape as a single-piece, cut-to-shape implant made entirely of resorbable materials. Its Toronto company page explicitly identifies fracture repair as under investigational testing.

Supports: Profile · profileData.currentActivity

Cohesys announced first-in-human investigational use of BoneTape in craniofacial fracture repair in 2025, and NATO DIANA lists it in the 2026 Canadian cohort.

Supports: Profile · reviewed questions.cohesys-delivery-question.confidence

Cohesys appears in NATO DIANA’s September 2, 2026 list of 15 Mission Track innovators selected from the 150-company cohort. The programme provides €300,000 in non-dilutive funding, test-centre access and adoption support; selection is not a procurement award.

Supports: Profile · reviewed questions.cohesys-delivery-question.context

Cohesys appears in NATO DIANA’s September 2, 2026 list of 15 Mission Track innovators selected from the 150-company cohort. The programme provides €300,000 in non-dilutive funding, test-centre access and adoption support; selection is not a procurement award.

Supports: Profile · reviewed questions.cohesys-delivery-question.question

Cohesys appears in NATO DIANA’s September 2, 2026 list of 15 Mission Track innovators selected from the 150-company cohort. The programme provides €300,000 in non-dilutive funding, test-centre access and adoption support; selection is not a procurement award.

Supports: Profile · current activity

Cohesys appears in NATO DIANA’s September 2, 2026 list of 15 Mission Track innovators selected from the 150-company cohort. The programme provides €300,000 in non-dilutive funding, test-centre access and adoption support; selection is not a procurement award.

Supports: Profile · executive relevance summary

Source location: executiveRelevanceSummary

Cohesys appears in NATO DIANA’s September 2, 2026 list of 15 Mission Track innovators selected from the 150-company cohort. The programme provides €300,000 in non-dilutive funding, test-centre access and adoption support; selection is not a procurement award.